| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/11/2009 | WO2009111493A1 Viral microrna |
| 09/11/2009 | WO2009111218A2 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | WO2009111064A2 Minocycline compounds and methods of use thereof |
| 09/11/2009 | WO2009110940A2 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 09/11/2009 | WO2009110644A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/11/2009 | WO2009110546A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/11/2009 | WO2009109860A2 Mutant forms of chlamydia htra |
| 09/11/2009 | WO2009109532A2 Use of defensins against tuberculosis |
| 09/11/2009 | WO2009109531A2 Combination therapy |
| 09/11/2009 | WO2009087151A9 Polymorphic forms of moxifloxacin hydrochloride and processes for preparation thereof |
| 09/11/2009 | WO2009071650A3 Amide compounds as boosters of antivirals |
| 09/11/2009 | WO2009067541A3 Integrase inhibitors |
| 09/11/2009 | WO2009061889A4 Grape polyphenolics for platelet and bacterial control |
| 09/11/2009 | WO2009040069A3 Use of bq-610 alone or in combination with helodermin as a therapeutic agent |
| 09/11/2009 | WO2009033821A3 Use of a peptide as a therapeutic agent |
| 09/11/2009 | WO2009033779A3 Nociceptin for use as a therapeutic agent |
| 09/11/2009 | WO2009033778A3 Mage-3 antigen and others for use as a therapeutic agent |
| 09/11/2009 | WO2009033775A3 Peptide alpmhir alone or in combination with peptide yvpfppf as therapeutic agent |
| 09/11/2009 | WO2009033732A3 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/11/2009 | WO2009033726A3 Use of cart (55-102), optionally in combination with tuftsin, as a therapeutic agent |
| 09/11/2009 | WO2009033683A3 Galanin message associated peptide alone or in combination with minigastrin as a therapeutic agent |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | WO2009019571A3 Method of dissolving essential oils in water |
| 09/11/2009 | WO2009005338A8 Solid forms ult-i, ult-2 and ult-3 of emtricitabine |
| 09/11/2009 | CA2754281A1 Combination therapy |
| 09/11/2009 | CA2717703A1 Minocycline compounds and methods of use thereof |
| 09/11/2009 | CA2717626A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/11/2009 | CA2717173A1 Antiviral therapeutic agents |
| 09/11/2009 | CA2717006A1 Use of defensins against tuberculosis |
| 09/11/2009 | CA2716838A1 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | CA2713989A1 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens |
| 09/11/2009 | CA2713728A1 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227670 antiviral fragrances for reduction of viruses causing common cold |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227659 Nucleolar targeting of therapeutics against HIV |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227637 Diaryl ureas for treating virus infections |
| 09/10/2009 | US20090227621 Naphthyridine derivatives having inhibitory activity against hiv integrase |
| 09/10/2009 | US20090227600 4-(pyrazine-2-yl) -pyrrolidine -2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227541 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics |
| 09/10/2009 | US20090227524 Antiviral therapeutic agents |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226548 Method of preventing, controlling and ameliorating urinary tract infections using a synergistic cranberry derivative and d-mannose composition |
| 09/10/2009 | US20090226541 Methods of reducing microbial contamination |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226527 Particulate-stabilized injectable pharmacutical compositions of posaconazole |
| 09/10/2009 | US20090226526 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 09/10/2009 | US20090226488 Vaccine comprising an attenuated pestivirus |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226423 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 09/10/2009 | US20090226414 Method for detecting infectious parvovirus in pharmaceutical preparations |
| 09/10/2009 | US20090226400 Continuous delivery methods for treating hepatitis virus infection |
| 09/10/2009 | US20090226398 Anti-viral compounds, compositions, and methods of use |
| 09/10/2009 | DE102008011692A1 Wirkstoffkombination und deren Verwendung Combination of active substances and their use |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098525A1 Crystalline carbapenem compound and produced method thereof |
| 09/09/2009 | EP2098238A1 Helicobacter pylori growth inhibitor containing -n-acetylglucosaminyl-binding monosaccharide derivative |
| 09/09/2009 | EP2097534A2 Human antibodies that bind cd70 and uses thereof |
| 09/09/2009 | EP2097440A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 09/09/2009 | EP2097434A2 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 09/09/2009 | EP2097423A2 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production |
| 09/09/2009 | EP2097402A1 Macrocyclic inhibitors of hepatitis c virus |
| 09/09/2009 | EP2097400A2 Fused substituted aminopyrrolidine derivative |
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2097103A1 Influenza vaccine formulation |
| 09/09/2009 | EP2097084A2 Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis c |
| 09/09/2009 | EP2097081A1 Cholesterylamines for the treatment and prevention of infectious diseases |
| 09/09/2009 | EP1902050B1 Oxazolidinone derivatives and use thereof as antibiotics |
| 09/09/2009 | EP1765370B1 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 09/09/2009 | EP1661982B1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 09/09/2009 | EP1644410B1 Sushi peptide multimer |
| 09/09/2009 | EP1556398B1 Novel cytarabine monophosphate prodrugs |
| 09/09/2009 | EP1523330B1 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1458447B1 Combination of cytochome p 450 dependent protease inhibitors |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1371370B1 Drugs containing reduced vitamin b2 |
| 09/09/2009 | EP1305296B1 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP1109562A4 Composite biocidal particles |
| 09/09/2009 | CN101525617A Eriocheir sinensis Crustin-1 gene and in-vitro recombination expression |
| 09/09/2009 | CN101525616A Preparation and application of sperm binding protein HEL-127 specifically expressed in human epididymis |
| 09/09/2009 | CN101525615A Defensins gene expressed in human epididymis, and cloning, expression and application of same |
| 09/09/2009 | CN101525610A Application of earthworm fibronectin enzyme in treating hepatitis B |
| 09/09/2009 | CN101525597A New hepatitis A inactivated vaccine virus strain and method for culturing same |
| 09/09/2009 | CN101525388A Specific double-strand RNA binding protein chimera and application thereof in virus infectious diseases |